Vericel to Report First-Quarter 2018 Financial Results on May 8, 2018
April 24 2018 - 7:00AM
Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell
therapies for the sports medicine and severe burn care markets,
today announced the following webcast and conference call to
discuss its first-quarter 2018 financial results and business
highlights.
What: |
|
Vericel Corporation
First-Quarter 2018 Earnings Call |
When: |
|
Tuesday, May 8, 2018 at
8:30am (EDT) |
Where: |
|
http://investors.vcel.com/events-presentations |
How: |
|
The conference call
will be available live in the Investors section of the Vericel
website at http://investors.vcel.com/events-presentations.
Please access the site at least 15 minutes prior to the
scheduled start time in order to download the required audio
software if necessary. |
To participate in the live call by telephone, please call (877)
312-5881 and reference Vericel Corporation first-quarter 2018
earnings call. If calling from outside the U.S., please use
the international phone number (253) 237-1173.
If you are unable to participate in the live call, the webcast
will be available at http://investors.vcel.com/events-presentations
until May 8, 2019. A replay of the call will also be
available until 11:30am (EDT) on May 13, 2018 by calling (855)
859-2056, or from outside the U.S. (404) 537-3406. The
conference ID is 1564056.
About Vericel CorporationVericel is a leader in
advanced cell therapies for the sports medicine and severe burn
care markets. The company markets two cell therapy products
in the United States. MACI® (autologous cultured chondrocytes
on porcine collagen membrane) is an autologous cellularized
scaffold product indicated for the repair of symptomatic, single or
multiple full-thickness cartilage defects of the knee with or
without bone involvement in adults. Epicel® (cultured
epidermal autografts) is a permanent skin replacement for the
treatment of patients with deep dermal or full thickness burns
greater than or equal to 30% of total body surface area. For
more information, please visit the company's website at
www.vcel.com.
Epicel® and MACI® are registered trademarks of Vericel
Corporation. © 2018 Vericel Corporation. All rights reserved.
VCEL-fin
Global Media Contacts:David SchullRusso
Partners LLC+1 212-845-4271 (office)+1 858-717-2310
(mobile)David.schull@russopartnersllc.com
Karen ChaseRusso Partners LLC+1 646-942-5627 (office)+1
917-547-0434 (mobile)Karen.chase@russopartnersllc.com
Investor Contacts: Chad RubinSolebury
Troutcrubin@troutgroup.com+1 (646) 378-2947
Lee SternSolebury Troutlstern@troutgroup.com+1 (646)
378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jul 2023 to Jul 2024